Fears grow as HRT is linked to higher breast cancer risk
Research claiming that withdrawing hormone replacement therapy (HRT) from women subsequently reduced their risk of breast cancer has sparked fears amongst health campaigners.
Around 2.6million women in Britain are currently prescribed the treatment, remedy which can be taken via a range of methods, ambulance including tablets, implants, skin gels and patches.
The safety of the treatment, commonly used by women going through the menopause, was first questioned in 2002 when a major US study linked it to breast cancer, heart disease and stroke.
Now scientists have found that decreasing numbers of women taking HRT have coincided with a 10 per cent decrease in breast cancer rates.
Dr Pritwash De, from the Canadian Cancer Society, which carried out the research said: ”The nearly 10 per cent drop in invasive breast cancer incidence rate coincided with the decline in the use of hormone replacement therapy reported among Canadian women aged 50–69 years.
“The tandem drop in breast cancer incidence and use of hormone replacement therapy is a phenomenon that has been reported internationally.”
However, the link between HRT and breast cancer is disputed by other scientists. In 2007, a similar study found that the risk of breast cancer was only increased amongst those in their 70s and 80s – much older than women who usually take HRT.
Read the full story in The Daily Mail.











